The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
about
Diagnostic Criteria in Attention Deficit Hyperactivity Disorder - Changes in DSM 5A systematic review of global publication trends regarding long-term outcomes of ADHDEffect of treatment modality on long-term outcomes in attention-deficit/hyperactivity disorder: a systematic reviewExposure to fluoridated water and attention deficit hyperactivity disorder prevalence among children and adolescents in the United States: an ecological associationFacts, values, and attention-deficit hyperactivity disorder (ADHD): an update on the controversiesPrevalence of attention deficit hyperactivity disorder among children and adolescents in Spain: a systematic review and meta-analysis of epidemiological studiesUnderstanding attention-deficit/hyperactivity disorder from childhood to adulthoodThe long-term outcomes of interventions for the management of attention-deficit hyperactivity disorder in children and adolescents: a systematic review of randomized controlled trialsLead and PCBs as risk factors for attention deficit/hyperactivity disorderA systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatmentToward systems neuroscience of ADHD: a meta-analysis of 55 fMRI studiesPsychostimulants and cognition: a continuum of behavioral and cognitive activationThe genetics of attention deficit/hyperactivity disorder in adults, a reviewLarge-scale brain systems in ADHD: beyond the prefrontal-striatal modelMeta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorderThe prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic reviewEvidence-based information on the clinical use of neurofeedback for ADHDAdvances in understanding and treating ADHDThe neurobiological basis of ADHDRare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genesAtomoxetine acts as an NMDA receptor blocker in clinically relevant concentrationsMedication for attention deficit-hyperactivity disorder and criminalityDCDC2, KIAA0319 and CMIP are associated with reading-related traitsDSM IV, culture and child psychiatryCritical appraisal of omega-3 fatty acids in attention-deficit/hyperactivity disorder treatmentA Review of Pharmacological Management of Attention-Deficit/Hyperactivity DisorderMoving towards causality in attention-deficit hyperactivity disorder: overview of neural and genetic mechanismsAttention deficit hyperactivity disorder and disordered eating behaviors: links, risks, and challenges facedThe Effects of Classroom Interventions on Off-Task and Disruptive Classroom Behavior in Children with Symptoms of Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic ReviewNatural Product-Derived Treatments for Attention-Deficit/Hyperactivity Disorder: Safety, Efficacy, and Therapeutic Potential of Combination TherapyComputational Psychiatry of ADHD: Neural Gain Impairments across Marrian Levels of AnalysisA critical appraisal of atomoxetine in the management of ADHDA randomized, double-blind, cross-over, phase IV trial of oros-methylphenidate (CONCERTA(®)) and generic novo-methylphenidate ER-C (NOVO-generic)Attention Deficit Hyperactivity Disorder in the Light of the Epigenetic ParadigmExpanding the toolbox of ADHD genetics. How can we make sense of parent of origin effects in ADHD and related behavioral phenotypes?Magnesium, Iron, and Zinc Supplementation for the Treatment of Attention Deficit Hyperactivity Disorder: A Systematic Review on the Recent LiteratureA systematic review of attention deficit hyperactivity disorder (ADHD) and mathematical ability: current findings and future implicationsDevelopment and applications of the SWAN rating scale for assessment of attention deficit hyperactivity disorder: a literature reviewUsing Sibling Designs to Understand Neurodevelopmental Disorders: From Genes and Environments to Prevention ProgrammingLong-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges
P2860
Q21129112-42A9C509-D868-4866-A528-E9DA48715AAAQ21129117-D9E94D02-D5B6-444B-B237-4A754B5DB2BEQ21131827-7CD673D0-87FE-4380-8093-0A67F5B5F7F7Q21146667-E97C7872-42D3-41B9-B9DB-BB91B34C121EQ21202070-F2B81629-CF14-43E9-8B80-70D3AF5CBAF3Q21260319-C3D9BBEB-DB6A-40BC-B27C-1ADDCF127BE0Q22241209-C2404624-86A8-4FE5-9BED-17B8D296EE87Q22241444-B3EEFE29-6736-4C8D-A163-D40C80E1F018Q22241574-C492C002-D919-40C1-82BD-8CC3EC05F9C5Q22241759-B70EF8A6-B434-4B42-8C0B-0C00DC5BC651Q22241857-2C09959B-D0BB-4374-B03C-6751D6B61632Q22242285-8AEAD561-CF6B-4710-BFAF-0BFF97FE8EDDQ22251103-B7B97344-2ADD-4FD5-9DEA-1C6789677914Q22251460-E782A437-A010-40E3-91BC-4315B806ECA8Q22252418-BB004604-8121-44A9-A88C-6493D9785AECQ22252567-D0E13E3F-F0AE-46A6-8FD0-0B0DE242B770Q24600947-55F8D3E1-3D33-4842-974B-693EFF2E6BCDQ24601949-7C84F65F-E5BF-4B36-8AA3-82A728E607A9Q24604400-249626C5-6310-4C2A-8E95-72F7A70F033BQ24605530-FB910778-35BC-4689-A13F-6D9848394D6CQ24607931-C58EE9B5-ED65-4459-8838-02FE4D459959Q24619697-A31D5F7E-5E8D-48E1-85D7-558F98E384A1Q24631427-ADEB3D68-216E-42DB-88F3-146316CCF400Q24653744-A1B4CD8F-1AA6-45D4-A7B4-CEF0FC340F7AQ26739640-9A80BBFE-E3FB-45F6-A04C-E1DB0DC79A94Q26741896-29285D80-684F-4EE9-862C-D599CD4C8155Q26749377-295EB5C3-A21B-4A5C-92F2-E57EC9394B45Q26752862-C5480D88-AB42-4206-BF11-E1F473ECED2CQ26765169-7C47CBB3-6BF1-4549-92F6-5761092A6804Q26766330-39CCDC8D-FD50-4C81-9899-D43A12164DE8Q26770889-3D55D269-4681-4F22-8FAE-82FD44572692Q26771187-31F457AA-3ACC-4F7B-92BC-ACAFDCE07B57Q26779556-766E369B-71F4-4953-9872-43AAD4640424Q26781527-5749ABD6-8AD6-45A0-969D-31D9994BCDF5Q26782150-3F2540A3-021B-4C25-AD7C-AA5C2755EBA2Q26786518-F7C483D2-AEB8-44C8-B5DB-7FFE266D5762Q26796493-0653766B-7334-4549-97DD-454C164AF708Q26796577-0640B5E3-F2A4-42AF-93C7-B43CBE3CB4E2Q26799923-3D31134A-0D9E-4D3C-AA83-FA5A8EEEE1DFQ26822392-AF877BFD-28FD-4EE7-854D-B3EF7AC4908B
P2860
The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
@ast
The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
@en
The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
@en-gb
type
label
The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
@ast
The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
@en
The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
@en-gb
prefLabel
The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
@ast
The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
@en
The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
@en-gb
P31
P3181
P1476
The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
@en
P2093
Guilherme Polanczyk
P3181
P356
10.1176/APPI.AJP.164.6.942
P407
P577
2007-06-01T00:00:00Z